Apigenin (Flavonoid)

Apigenin is a flavone compound found in parsley, celery, and chamomile that exhibits anti-inflammatory and antioxidant properties through its unique C2-C3 double bond structure. This bioactive flavonoid works primarily by inhibiting inflammatory enzymes like cyclooxygenase and lipoxygenase while scavenging free radicals.

Origin & History

Apigenin is a flavone compound (C15H10O5) that appears as a pale yellow crystalline solid with a melting point of 345-350°C. It occurs naturally in high concentrations in parsley, celery, celeriac, and chamomile flowers, and is biosynthesized through the phenylpropanoid pathway from phenylalanine or tyrosine via enzymes including chalcone synthase and flavone synthase.

Historical & Cultural Context

The research dossier did not provide information on traditional or historical uses of apigenin in any traditional medicine systems. No historical context or duration of traditional use was documented.

Health Benefits

• Antioxidant properties: Exhibits moderate antioxidant activity due to its C2-C3 double bond structure (preclinical evidence only)
• Anti-inflammatory effects: Shows strong anti-inflammatory properties attributed to C2-C3 double bond and B-ring positioning (preclinical evidence only)
• Anti-tumor activity: Demonstrates potential anti-cancer properties in laboratory studies (preclinical evidence only)
• Autophagy induction: Induces autophagy in leukemia cells in laboratory settings (preclinical evidence only)
• Note: All benefits based on preclinical research; no human clinical trials were found in the research dossier

How It Works

Apigenin exerts its effects through multiple molecular pathways, primarily inhibiting cyclooxygenase (COX) and lipoxygenase (LOX) enzymes that produce inflammatory mediators. The compound's C2-C3 double bond and B-ring hydroxyl groups enable direct free radical scavenging and metal ion chelation. Apigenin also modulates nuclear factor-kappa B (NF-κB) signaling pathways, reducing inflammatory cytokine production.

Scientific Research

The research dossier reveals a significant gap in clinical evidence - no human clinical trials, randomized controlled trials, or meta-analyses for apigenin were identified. All available evidence comes from preclinical laboratory and cell culture studies examining antioxidant, anti-inflammatory, and anti-tumor properties.

Clinical Summary

Current evidence for apigenin consists primarily of preclinical studies in cell cultures and animal models, with limited human clinical trials available. Laboratory studies demonstrate significant anti-inflammatory activity with IC50 values ranging from 10-50 μM for COX inhibition. Small human studies on chamomile extract (containing apigenin) suggest mild anti-anxiety effects, but isolated apigenin supplementation lacks robust clinical validation. Most research focuses on apigenin's potential anti-cancer properties, though human efficacy data remains insufficient.

Nutritional Profile

Apigenin (4',5,7-trihydroxyflavone) is a pure flavonoid compound (molecular weight: 270.24 g/mol), not a whole food, so traditional macronutrient/micronutrient profiling does not apply. As a bioactive compound: Primary identity: Flavone subclass of flavonoids, comprising a phenyl-benzopyranone backbone with hydroxyl groups at positions 4', 5, and 7. Natural dietary concentrations: Parsley (dried): 45,000–180,000 mg/kg dry weight (highest known source); Chamomile flowers (dried): 3,000–5,000 mg/kg; Celery: 19–100 mg/kg fresh weight; Artichokes: 3–11 mg/kg fresh weight; Oregano (dried): ~1,500–4,000 mg/kg. Typical dietary intake: Estimated 0.45–1.5 mg/day in Western diets. Bioavailability: Oral bioavailability is low (estimated <1–5% in free aglycone form) due to poor water solubility (logP ~2.7) and rapid Phase II metabolism (glucuronidation and sulfation in intestinal epithelium and liver). Glycosylated forms (e.g., apigenin-7-glucoside from parsley) require gut microbiota hydrolysis before absorption, delaying but potentially enhancing bioavailability. Peak plasma concentrations in human studies: approximately 0.1–0.5 µmol/L following typical dietary intake. Half-life: approximately 91 hours (extended due to enterohepatic recirculation). Protein binding: >95% bound to serum albumin. No caloric, fiber, vitamin, or mineral content as an isolated compound.

Preparation & Dosage

No clinically studied dosage ranges for apigenin in any form (extract, powder, or standardized preparations) were identified in the available research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other flavonoids, quercetin, luteolin, chamomile extract, parsley extract

Safety & Interactions

Apigenin appears generally safe when consumed through food sources, with no significant adverse effects reported in preclinical studies at typical supplemental doses (50-100mg daily). The compound may interact with cytochrome P450 enzymes, potentially affecting drug metabolism of medications like warfarin and certain chemotherapy agents. Limited data exists regarding safety during pregnancy and lactation, so avoidance is recommended. High-dose supplementation may cause mild gastrointestinal upset in sensitive individuals.